Vr Adviser, LLC Celldex Therapeutics, Inc. Transaction History

Vr Adviser, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 15, 2023	SELL	$22.7 - $37.57 $17.9 Million - $29.7 Million	-790,116 Reduced 91.33%	75,000 $2.11 Million
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $17.9 Million - $29.7 Million	-790,116 Reduced 91.33%	75,000 $2.11 Million
Q2 2022 May 15, 2023	BUY	$20.5 - $37.33 $17.7 Million - $32.3 Million	865,116 New	865,116 $23.3 Million
Q4 2021 Feb 14, 2022	SELL	$35.68 - $56.27 $8.32 Million - $13.1 Million	-233,058 Reduced 21.22%	865,116 $33.4 Million
Q3 2021 Nov 15, 2021	SELL	$28.95 - $55.99 $4.12 Million - $7.97 Million	-142,436 Reduced 11.48%	1,098,174 $59.3 Million
Q1 2021 May 14, 2021	BUY	$16.19 - $29.91 $7.13 Million - $13.2 Million	440,610 Added 55.08%	1,240,610 $25.6 Million
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $7.72 Million - $12.2 Million	800,000 New	800,000 $11.9 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.